Literature DB >> 17668313

Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents.

Georgina Giocos1, Ashraf Kagee, Leslie Swartz.   

Abstract

The present study sought to determine whether the Theory of Planned Behaviour predicted stated hypothetical willingness to participate (WTP) in future Phase III HIV vaccine trials among South African adolescents. Hierarchical logistic regression analyses showed that The Theory of Planned Behaviour (TPB) significantly predicted WTP. Of all the predictors, Subjective norms significantly predicted WTP (OR = 1.19, 95% C.I. = 1.06-1.34). A stepwise logistic regression analysis revealed that Subjective Norms (OR = 1.19, 95% C.I. = 1.07-1.34) and Attitude towards participation in an HIV vaccine trial (OR = 1.32, 95% C.I. = 1.00-1.74) were significant predictors of WTP. The addition of Knowledge of HIV vaccines and HIV vaccine trials, Perceived self-risk of HIV infection, Health-promoting behaviours and Attitudes towards HIV/AIDS yielded non-significant results. These findings provide support for the Theory of Reasoned Action (TRA) and suggest that psychosocial factors may play an important role in WTP in Phase III HIV vaccine trials among adolescents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17668313     DOI: 10.1007/s10461-007-9289-5

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  11 in total

1.  Socioecological influences on community involvement in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Brooke Hixson; Carlos del Rio
Journal:  Vaccine       Date:  2011-06-29       Impact factor: 3.641

2.  Adolescent and Parent Perceptions about Participation in Biomedical Sexual Health Trials.

Authors:  Sara E Landers; Jenny K R Francis; Marilyn C Morris; Christine Mauro; Susan L Rosenthal
Journal:  Ethics Hum Res       Date:  2020-05

3.  An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Dazon Dixon Diallo; Su-I Hou; Takeia Horton; Kayshin Chan; Mark J Mulligan; Carlos del Rio
Journal:  Prev Sci       Date:  2010-06

4.  Characteristics of female sex workers in southern India willing and unwilling to participate in a placebo gel trial.

Authors:  Barbara S Mensch; Barbara A Friedland; Sharon A Abbott; Lauren L Katzen; Waimar Tun; Christine A Kelly; Avina Sarna; Aylur K Srikrishnan; Suniti Solomon
Journal:  AIDS Behav       Date:  2013-02

5.  Preventive misconception and adolescents' knowledge about HIV vaccine trials.

Authors:  Mary A Ott; Andreia B Alexander; Michelle Lally; John B Steever; Gregory D Zimet
Journal:  J Med Ethics       Date:  2013-01-25       Impact factor: 2.903

6.  Adolescents and Their Parents Differ on Descriptions of a Reproductive Health Study.

Authors:  Jenny K R Francis; Lily F Hoffman; Mei-Chen Hu; Ariel M de Roche; Marina Catallozzi; Carmen Radecki Breitkopf; Susan L Rosenthal
Journal:  J Pediatr Adolesc Gynecol       Date:  2015-09-25       Impact factor: 1.814

7.  The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants.

Authors:  Jonathan E Volk; Nancy A Hessol; Glenda E Gray; James G Kublin; Gavin J Churchyard; Koleka Mlisana; Maphoshane Nchabeleng; Susan P Buchbinder; Linda-Gail Bekker
Journal:  Int J STD AIDS       Date:  2013-10-08       Impact factor: 1.359

8.  Inclusion of South African adolescents in HIV vaccine trials.

Authors:  David H Adler
Journal:  J AIDS HIV Res       Date:  2012-02-01

9.  Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users.

Authors:  Shayesta Dhalla; Gary Poole; Joel Singer; David M Patrick; Evan Wood; Thomas Kerr
Journal:  Vaccine       Date:  2009-12-29       Impact factor: 3.641

10.  Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.

Authors:  Gershim Asiki; Andrew Abaasa; Eugene Ruzagira; Freddie Kibengo; Ubaldo Bahemuka; Jerry Mulondo; Janet Seeley; Linda-Gail Bekker; Sinead Delany; Pontiano Kaleebu; Anatoli Kamali
Journal:  Vaccine       Date:  2013-09-07       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.